Clinical Trial Update: Effect of Cerebrolysin on the Blood Brain Barrier in Patients With Diabetes and Ischemic Stroke [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating the effect of Cerebrolysin on the blood-brain barrier in patients with acute ischemic stroke and type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke
• Type 2 Diabetes Mellitus

Drugs mentioned

• Cerebrolysin

Snippet

Sponsor: Hospital Universitario Dr. Jose E. Gonzalez | Conditions: Ischemic Stroke, Acute, Diabetes Mellitus, Type 2 | Phase 4 | Status: UNKNOWN